GE HEALTHCARE TECHNOLOGIES INC.

NASDAQ: GEHC (GE HealthCare Technologies Inc.)

最近更新时间: 4天之前, 1:54PM

78.91

1.48 (1.91%)

前收盘价格 77.43
收盘价格 77.02
成交量 11,179,862
平均成交量 (3个月) 3,294,018
市值 36,051,849,216
市盈率 (P/E TTM) 21.62
预期市盈率 (P/E Forward) 17.15
价格/销量 (P/S) 1.86
股市价格/股市净资产 (P/B) 4.36
52周波幅
71.31 (-9%) — 94.55 (19%)
利润日期 13 Feb 2025
股息率 (DY TTM) 0.15%
营业毛利率 8.56%
营业利益率 (TTM) 16.06%
稀释每股收益 (EPS TTM) 3.65
季度收入增长率 (YOY) 0.90%
季度盈利增长率 (YOY) 25.30%
总债务/股东权益 (D/E MRQ) 126.09%
流动比率 (MRQ) 1.23
营业现金流 (OCF TTM) 2.09 B
杠杆自由现金流 (LFCF TTM) 1.82 B
资产报酬率 (ROA TTM) 5.64%
股东权益报酬率 (ROE TTM) 21.85%

市场趋势

短期 中期
行业 Health Information Services (US) 混合的 看跌
Health Information Services (全球的) 混合的 看跌
股票 GE HealthCare Technologies Inc. 看涨 看涨

AIStockmoo 评分

0.6
分析师共识 3.5
内部交易活动 NA
价格波动 2.0
技术平均移动指标 -2.5
技术振荡指标 -0.5
平均 0.63

相关股票

股票 市值 DY P/E(TTM) P/B
GEHC 36 B 0.15% 21.62 4.36
HQY 8 B - 87.11 3.90
RCM 6 B - - 2.14
TEM 5 B - - 100.48
WAY 5 B - - 1.74
PRVA 2 B - 180.91 3.89

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).

部门 Healthcare
行业 Health Information Services
投资方式 Mid Core
内部持股比例 3.09%
机构持股比例 83.55%
52周波幅
71.31 (-9%) — 94.55 (19%)
目标价格波幅
74.00 (-6%) — 102.00 (29%)
102.00 (Evercore ISI Group, 29.26%) 购买
102.00 (Stifel, 29.26%) 购买
99.00 (25.46%)
74.00 (UBS, -6.22%) 卖出
平均值 93.50 (18.49%)
总计 3 购买, 1 卖出
平均价格@调整类型 91.34
公司 日期 目标价格 调整类型 价格@调整类型
Wells Fargo 31 Oct 2024 96.00 (21.66%) 购买 87.35
Evercore ISI Group 01 Oct 2024 102.00 (29.26%) 购买 91.67
Stifel 30 Sep 2024 102.00 (29.26%) 购买 93.85
UBS 26 Sep 2024 74.00 (-6.22%) 卖出 92.49

该时间范围内无数据。

日期 类型 细节
12 Dec 2024 公告 GE HealthCare to announce fourth quarter and full year 2024 results on February 13, 2025
05 Dec 2024 公告 GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide
04 Dec 2024 公告 GE HealthCare showcases commitment to sustainable innovation at RSNA 2024
03 Dec 2024 公告 GE HealthCare announces 510(k) submission for CleaRecon DL technology designed to improve image quality in the interventional suite with AI-based reconstruction
01 Dec 2024 公告 GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
01 Dec 2024 公告 GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI
01 Dec 2024 公告 GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024
26 Nov 2024 公告 GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care
25 Nov 2024 公告 GE HealthCare management to present at upcoming investor conferences
22 Nov 2024 公告 GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology
21 Nov 2024 公告 GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth
18 Nov 2024 公告 Pilot Study Showcases the Value of Portrait Mobile Continuous Monitoring Solution to Encourage Clinical Intervention While Mitigating Alarm Fatigue
13 Nov 2024 公告 GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System
12 Nov 2024 公告 GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage
11 Nov 2024 公告 GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
11 Nov 2024 公告 GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
07 Nov 2024 公告 GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares
07 Nov 2024 公告 GE HealthCare to Host its 2024 Investor Day on November 21
07 Nov 2024 公告 GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares
30 Oct 2024 公告 GE HealthCare reports third quarter 2024 financial results
21 Oct 2024 公告 GE HealthCare Announces AI Innovation Lab Showcasing Five New Research Projects
21 Oct 2024 公告 GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view
18 Oct 2024 公告 GE HealthCare, the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation commit $1M to improve Milwaukee health outcomes
17 Oct 2024 公告 GE HealthCare announces major academic medical center as first customer to adopt new Hospital Pulse Tile for Command Center
16 Oct 2024 公告 A New Theranostics Center of Excellence in Europe: GE HealthCare and University Medicine Essen Collaborate to Advance Theranostics and Personalized Medicine
14 Oct 2024 公告 GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system
09 Oct 2024 公告 GE HealthCare Accelerates Artificial Intelligence Adoption With New Offering to Advance Enterprise Imaging
08 Oct 2024 公告 GE HealthCare to announce third quarter 2024 results on October 30, 2024
07 Oct 2024 公告 GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe
07 Oct 2024 公告 GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
27 Sep 2024 公告 GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
26 Sep 2024 公告 GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024
显示更多
股息率 (DY TTM) 0.15%
1年平均股息收益率 0.12%
股息支付比率 3.29%
预计下次股息支付 May 2025
除息日 公告日期 支付日期 详情
14 Jan 2025 21 Nov 2024 14 Feb 2025 0.035 现金
18 Oct 2024 18 Sep 2024 15 Nov 2024 0.03 现金
19 Jul 2024 26 Jun 2024 15 Aug 2024 0.03 现金
18 Apr 2024 22 Mar 2024 15 May 2024 0.03 现金
12 Jan 2024 08 Dec 2023 15 Feb 2024 0.03 现金
19 Oct 2023 22 Sep 2023 15 Nov 2023 0.03 现金
20 Jul 2023 23 Jun 2023 15 Aug 2023 0.03 现金
22 May 2023 25 Apr 2023 15 Jun 2023 0.03 现金

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2024 0.120 4 0.15
2023 0.090 3 0.12

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2024 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票